New insights into membranous glomerulonephritis: from bench to bedside.
Open Access
- 28 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (8) , 2428-30
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2011
- In vivo characterization of renal auto‐antigens involved in human auto‐immune diseases: The case of membranous glomerulonephritisProteomics – Clinical Applications, 2010
- Rituximab Therapy in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2010
- Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2Journal of the American Society of Nephrology, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Rituximab for membranous nephropathy and immune disease: less might be enoughNature Clinical Practice Nephrology, 2008
- Pathomechanisms and molecular basis of membranous glomerulopathyThe Lancet, 2004
- Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathiesThe Lancet, 2004
- Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase AntibodiesNew England Journal of Medicine, 2002
- Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1984